Fig. 2From: Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysisForest map of summary estimates for comparison of mortality between BCAA and control groups. a) 1-year mortality; b) 3-year mortalityBack to article page